Phase 3 Study of Facilitated Subcutaneous Immunoglobulin in Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP): Interim Analysis of Immunogenicity

被引:0
|
作者
Hasan, Shabbir [1 ]
Ay, Hakan [1 ,2 ]
Duff, Kimberly [1 ]
Chavan, Shailesh [1 ]
机构
[1] Takeda, Cambridge, MA USA
[2] Harvard Med Sch, Massachusetts Gen Hosp, Boston, MA 02115 USA
关键词
D O I
暂无
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
4194
引用
收藏
页数:2
相关论文
共 50 条
  • [1] Immunogenicity in a Phase 3 facilitated subcutaneous immunoglobulin study in chronic inflammatory demyelinating polyradiculoneuropathy (CIDP)
    Hasan, Shabbir
    Wisseh, Steve
    Ay, Hakan
    Duff, Kim
    Nagy, Andras
    Chavan, Shailesh
    JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM, 2020, 25 (04) : 538 - 538
  • [2] IMMUNOGENICITY IN A PHASE 3 FACILITATED SUBCUTANEOUS IMMUNOGLOBULIN STUDY IN CHRONIC INFLAMMATORY DEMYELINATING POLYRADICULONEUROPATHY
    Hasan, Shabbir
    Wisseh, Steve
    Ay, Hakan
    Duff, Kim
    Nagy, Andras
    Chavan, Shailesh
    MUSCLE & NERVE, 2020, 62 : S66 - S66
  • [3] Phase III study of subcutaneous immunoglobulin IGHy and intravenous immunoglobulin for chronic inflammatory demyelinating polyradiculoneuropathy
    Glyman, Steve
    Wisseh, Steve
    Duff, Kim
    Hasan, Shabbir
    Nagy, Andras
    JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM, 2018, 23 (04) : 400 - 400
  • [4] Chronic inflammatory demyelinating polyradiculoneuropathy (CIDP)
    Kaulen, Barbara
    Hagemann, Laura
    Lehmann, Helmar C.
    FORTSCHRITTE DER NEUROLOGIE PSYCHIATRIE, 2024, 92 (06) : e1 - e1
  • [5] GAIT ANALYSIS IN CHRONIC INFLAMMATORY DEMYELINATING POLYRADICULONEUROPATHY (CIDP)
    Coraci, Daniele
    Campagnolo, Marta
    Bahadori, Mehrdad
    Cacciavillani, Mario
    Di Marco, Roberto
    Masiero, Stefano
    Briani, Chiara
    JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM, 2022, 27 : S9 - S9
  • [6] Subcutaneous immunoglobulin. Treatment in chronic inflammatory demyelinating polyradiculoneuropathy
    Nogues, Martin A.
    Varela, Francisco J.
    Seminario, Gisela
    Insua, Maria C.
    Bezrodnik, Liliana
    MEDICINA-BUENOS AIRES, 2016, 76 (01) : 36 - 39
  • [7] Fatigability and chronic inflammatory demyelinating polyradiculoneuropathy (CIDP)
    Boukhris, S. A.
    Magy, L. A.
    Gallouedec, G. A.
    Khalil, M. O.
    Altmann, E. M.
    Tabaraud, F. R.
    Moreau, J. A.
    Vallat, J. M.
    EUROPEAN JOURNAL OF NEUROLOGY, 2004, 11 : 144 - 145
  • [8] Intravenous immunoglobulin (IVIg) in untreated patients with chronic inflammatory demyelinating polyradiculoneuropathy (CIDP)
    Mendell, JR
    Barohn, RJ
    Kissel, JT
    Sanders, MC
    King, WM
    Campbell, WM
    Donofrio, PD
    Jackson, CE
    Lewis, RA
    Simpson, DM
    Parry, GJ
    Thornton, CA
    Bromberg, MB
    Rivner, MH
    Tandan, R
    Harati, Y
    Wrubel, BT
    Giuliani, MJ
    NEUROLOGY, 2000, 54 (07) : A212 - A212
  • [9] SUBCUTANEOUS IMMUNOGLOBULIN (SCIG) FOR TREATMENT OF CHRONIC INFLAMMATORY DEMYELINATING POLYRADICULONEUROPATHY (CIDP): A SINGLE CENTER EXPERIENCE IN 5 PATIENTS
    Cosentino, G.
    Baschi, R.
    Romano, M.
    Fierro, B.
    Brighina, F.
    JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM, 2016, 21 : S12 - S13
  • [10] Phase 3 study of HyQvia for chronic inflammatory demyelinating polyradiculoneuropathy (CIDP): ADVANCE-CIDP 1 infusion protocol
    Hasan, Shabbir
    Duff, Kim
    Nagy, Andras
    Boudjemia, Karima
    Yel, Leman
    JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM, 2020, 25 : S11 - S11